Title | Type | SJR | H index | Total Docs. (2013) | Total Docs. (3years) | Total Refs. (2013) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2013) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
171 | EPC - European Pharmaceutical Contractor | journal | 0.100 Q4 | 3 | 51 | 190 | 208 | 1 | 183 | 0.01 | 4.08 | |
170 | Next Generation Pharmaceutical | trade journal | 0.100 Q4 | 1 | 0 | 112 | 0 | 0 | 57 | 0.00 | 0.00 | |
169 | Pharmaceutical Manufacturing and Packing Sourcer | trade journal | 0.100 Q4 | 3 | 53 | 208 | 82 | 1 | 205 | 0.01 | 1.55 | |
168 | PharmacoVigilance Review | journal | 0.100 Q4 | 2 | 9 | 66 | 32 | 1 | 44 | 0.00 | 3.56 | |
167 | Pharmacy News | journal | 0.100 Q4 | 1 | 0 | 244 | 0 | 0 | 93 | 0.00 | 0.00 | |
166 | Sp2 | trade journal | 0.100 Q4 | 2 | 51 | 146 | 29 | 0 | 130 | 0.00 | 0.57 | |
165 | Manufacturing Chemist | trade journal | 0.101 Q4 | 6 | 138 | 347 | 275 | 2 | 316 | 0.00 | 1.99 | |
164 | Life Science Clusters | trade journal | 0.102 Q4 | 0 | 0 | 11 | 0 | 0 | 10 | 0.00 | 0.00 | |
163 | RSC Drug Discovery Series | book series | 0.102 Q4 | 13 | 0 | 28 | 0 | 0 | 11 | 0.00 | 0.00 | |
162 | EBR - European Biopharmaceutical Review | journal | 0.103 Q4 | 6 | 59 | 175 | 456 | 6 | 173 | 0.03 | 7.73 | |
161 | GMP Review | trade journal | 0.103 Q4 | 2 | 16 | 40 | 31 | 2 | 39 | 0.05 | 1.94 | |
160 | Pharmaceutical Journal | journal | 0.105 Q4 | 28 | 0 | 2299 | 0 | 39 | 877 | 0.02 | 0.00 | |
159 | Drugs in Context | journal | 0.107 Q4 | 36 | 13 | 3 | 461 | 0 | 3 | 0.00 | 35.46 | |
158 | Quality Assurance Journal | journal | 0.107 Q4 | 11 | 0 | 24 | 0 | 3 | 22 | 0.15 | 0.00 | |
157 | Industrial Pharmacy | trade journal | 0.117 Q4 | 5 | 19 | 40 | 102 | 8 | 40 | 0.20 | 5.37 | |
156 | International Journal of Green Nanotechnology | journal | 0.122 Q4 | 5 | 10 | 0 | 308 | 0 | 0 | 0.00 | 30.80 | |
155 | Innovations in Pharmaceutical Technology | trade journal | 0.123 Q4 | 9 | 59 | 81 | 205 | 10 | 76 | 0.12 | 3.47 | |
154 | Regulatory Rapporteur | trade journal | 0.127 Q3 | 7 | 78 | 212 | 489 | 16 | 164 | 0.09 | 6.27 | |
153 | Journal of Applied Therapeutic Research | journal | 0.128 Q4 | 8 | 0 | 25 | 0 | 5 | 25 | 0.06 | 0.00 | |
152 | ONdrugDelivery | trade journal | 0.142 Q3 | 7 | 47 | 128 | 188 | 11 | 109 | 0.07 | 4.00 | |
151 | Drug Discovery World | journal | 0.156 Q4 | 14 | 44 | 139 | 473 | 26 | 124 | 0.15 | 10.75 | |
150 | Issues in Toxicology | book series | 0.160 Q4 | 18 | 40 | 122 | 8309 | 50 | 114 | 0.27 | 207.73 | |
149 | Journal of Generic Medicines (discontinued) | journal | 0.160 Q3 | 16 | 32 | 105 | 481 | 32 | 91 | 0.27 | 15.03 | |
148 | European Pharmaceutical Review | trade journal | 0.166 Q3 | 9 | 64 | 122 | 986 | 26 | 120 | 0.30 | 15.41 | |
147 | Journal of Venomous Animals and Toxins Including Tropical Diseases | journal | 0.180 Q4 | 41 | 12 | 210 | 500 | 114 | 188 | 0.45 | 41.67 | |
146 | Journal of Pharmaceutical Health Services Research | journal | 0.190 Q3 | 19 | 35 | 100 | 994 | 52 | 89 | 0.52 | 28.40 | |
145 | International Journal of Computational Biology and Drug Design | journal | 0.200 Q4 | 16 | 27 | 75 | 720 | 34 | 68 | 0.46 | 26.67 | |
144 | Chemical Speciation and Bioavailability | journal | 0.218 Q4 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
143 | F1000Research | journal | 0.224 Q2 | 105 | 150 | 47 | 5217 | 21 | 43 | 0.45 | 34.78 | |
142 | Pharmaceutical Medicine | journal | 0.263 Q3 | 25 | 16 | 82 | 651 | 70 | 64 | 0.93 | 40.69 | |
141 | ATLA Alternatives to Laboratory Animals | journal | 0.264 Q4 | 65 | 88 | 224 | 1608 | 150 | 168 | 0.62 | 18.27 | |
140 | European Journal of Parenteral and Pharmaceutical Sciences | journal | 0.270 Q2 | 7 | 30 | 59 | 159 | 15 | 47 | 0.28 | 5.30 | |
139 | Autonomic and Autacoid Pharmacology | journal | 0.282 Q3 | 24 | 7 | 39 | 217 | 21 | 39 | 0.67 | 31.00 | |
138 | Drug Discovery Today: Disease Models | journal | 0.288 Q3 | 33 | 34 | 76 | 1646 | 53 | 67 | 0.70 | 48.41 | |
137 | BMC pharmacology & toxicology | journal | 0.312 Q3 | 43 | 62 | 21 | 1946 | 17 | 18 | 0.81 | 31.39 | |
136 | IDrugs : the investigational drugs journal | journal | 0.322 Q3 | 39 | 0 | 176 | 0 | 180 | 176 | 0.00 | 0.00 | |
135 | Journal of Labelled Compounds and Radiopharmaceuticals | journal | 0.322 Q3 | 54 | 113 | 377 | 4250 | 308 | 373 | 0.99 | 37.61 | |
134 | DARU, Journal of Pharmaceutical Sciences | journal | 0.338 Q3 | 58 | 78 | 205 | 2079 | 289 | 193 | 1.35 | 26.65 | |
133 | EPMA Journal | journal | 0.341 Q3 | 52 | 8 | 120 | 745 | 172 | 108 | 1.40 | 93.13 | |
132 | Cutaneous and Ocular Toxicology | journal | 0.347 Q3 | 37 | 72 | 184 | 1712 | 216 | 179 | 1.11 | 23.78 | |
131 | Journal of Chemotherapy | journal | 0.347 Q3 | 56 | 53 | 241 | 1935 | 246 | 205 | 1.06 | 36.51 | |
130 | Toxin Reviews | journal | 0.353 Q3 | 54 | 10 | 31 | 647 | 45 | 30 | 0.85 | 64.70 | |
129 | HIV Therapy | journal | 0.359 Q3 | 14 | 0 | 48 | 0 | 32 | 37 | 0.00 | 0.00 | |
128 | Journal of Pharmaceutical Policy and Practice | journal | 0.359 Q1 | 32 | 11 | 48 | 287 | 36 | 34 | 0.91 | 26.09 | |
127 | International Journal of Pharmacy Practice | journal | 0.374 Q2 | 44 | 59 | 244 | 1513 | 203 | 223 | 1.06 | 25.64 | |
126 | Personalized Medicine | journal | 0.392 Q3 | 36 | 93 | 271 | 3420 | 289 | 214 | 0.98 | 36.77 | |
125 | Pharmaceutical patent analyst | journal | 0.403 Q2 | 20 | 33 | 42 | 441 | 28 | 29 | 0.67 | 13.36 | |
124 | Immunopharmacology and Immunotoxicology | journal | 0.417 Q3 | 61 | 94 | 335 | 3689 | 509 | 332 | 1.47 | 39.24 | |
123 | Journal of Food Biochemistry | journal | 0.436 Q3 | 64 | 87 | 332 | 2957 | 384 | 326 | 1.04 | 33.99 | |
122 | Journal of Asian Natural Products Research | journal | 0.442 Q2 | 51 | 171 | 504 | 3457 | 624 | 503 | 1.17 | 20.22 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®